Trial reportJAMA network open2025
Radiotherapy and Smell Function in Head and Neck Cancer: A Nonrandomized Clinical Trial.
Trial report in JAMA network open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Importance: A substantial proportion of patients with head and neck cancer (HNC) experience smell dysfunction during or after radiotherapy (RT). However, prospectively collected data for smell dysfunction have been limited, especially in the era of intensity-modulated RT (IMRT). Objective: To evaluate the association of RT with olfactory function in patients with HNC receiving IMRT, including changes in olfactory function over time. Design, Setting, and Participants: This nonrandomized clinical trial enrolled patients with histologically confirmed HNC between January 1, 2021, and December 1, 2023, who underwent curative treatment with IMRT at Chang Gung Memorial Hospital in Taiwan. Participants scheduled for RT underwent olfactory function assessment using the Taiwan Smell Identification Test at multiple time points, including before RT; at the end of RT; and at 1, 3, 6, and 12 months after treatment. Nasal endoscopy was used to rule out confounding nasal conditions. Exposure: Intensity-modulated RT with and without concurrent chemotherapy. Main Outcomes and Measures: The association between Taiwan Smell Identification Test scores and olfactory region radiation dose was analyzed using linear regression, and an estimative model was developed to calculate a threshold dose. Results: A total of 63 patients (median [range] age, 55 [32-75] years; 52 male [82.5%]) with normal olfactory function before RT were included. The most common primary cancer site was the oral cavity and oropharynx (37 participants [58.7%]), followed by the nasopharynx (16 participants [25.4%]). A moderate positive correlation was observed between radiation dose and olfactory dysfunction. Receiver operating characteristic analysis identified 22 Gy as a potential inflection point for estimating olfactory impairment. By multivariable analysis, a mean radiation dose to the olfactory region exceeding 22 Gy was the only independent risk factor for olfactory dysfunction (odds ratio, 20.65; 95% CI, 2.60-164.35). Some patients treated with high-dose radiation experienced persistent olfactory dysfunction of up to 1 year. Conclusions and Relevance: This study found a dose-dependent association between RT and olfactory dysfunction in patients with HNC, identifying 22 Gy as an important inflection point. To minimize the risk of long-term olfactory impairment, optimizing RT planning by carefully adjusting radiation dose and target area may be beneficial. Trial Registration: ISRCTN14947812.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.